# Ustekinumab

## Stelara inj 45mg/0.5mL

| 藥物代碼           | ISTE                                                                                                                                                                                                                                                                                                                                                                                           |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Plaque psoriasis: Treatment of moderate to severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapyPsoriatic arthritis: Treatment of active psoriatic arthritis (as monotherapy or in combination with methotrexate) in adults.                                                                                                                               |
| 副作用             | Infection: Infection (27% to 70%; severe infection: ?3%)Central nervous system: Headache (5%), fatigue (3%), dizziness (2%), depression (1%)Dermatologic: Pruritus (2%)Gastrointestinal: Nausea (3%) Immunologic: Antibody development (3% to 6%)Local: Erythema at injection site (1% to 2%)Neuromuscular & skeletal: Arthralgia (3%), back pain (2%)Respiratory: Pharyngolaryngeal pain (2%) |
| 禁忌               | Hypersensitivity to ustekinumab or to any of the excipients of Stelara. Clinically important, active infection                                                                                                                                                                                                                                                                                 |
| 藥物保存方式       | 2-8°C                                                                                                                                                                                                                                                                                                                                                                                          |
| 用法用量           | Adult : Initial and maintenance: <=100 kg: 45 mg SC at 0 and 4 weeks, and then every 12 weeks thereafter.  >100 kg: 90 mg at 0 and 4 weeks, and then every 12 weeks thereafter. Consideration should be given to discontinuing the treatment in patients who have shown no response up to 28 weeks of treatment.                                                                               |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                   |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                   |
| 懷孕用藥危分級     | 可能安全                                                                                                                                                                                                                                                                                                                                                                                       |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                            |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                            |
| 哺乳期用藥建議     | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                                                                                                                                                                 |
| 附帶說明           | 以上懷孕及哺乳分級參考自藥品仿單。                                                                                                                                                                                                                                                                                                                                                             |
| 注射劑給藥建議途徑 | SC                                                                                                                                                                                                                                                                                                                                                                                             |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                            |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                            |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                            |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                            |
| 注意事項           | Administration: Stelara is for SC injection. If possible, areas of the skin that show psoriasis should be avoided as injection sites.                                                                                                                                                                                                                                                          |

